[Impact of different admission ways on treatment efficiency in patients with acute ST-segment elevation myocardial

C Y Cui1, M G Zhou1, A F Chen2

  • 1Department of Cardiology, Third People's Hospital of Chengdu Affiliated to Southwest Jiaotong University, Chengdu 610031, China.

Insights

Patients with ST-segment elevation myocardial infarction (STEMI) arriving by ambulance received faster percutaneous coronary intervention. However, admission method did not affect in-hospital mortality for these STEMI patients.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Public Health

Background:

  • Acute ST-segment elevation myocardial infarction (STEMI) requires timely reperfusion therapy.
  • Percutaneous coronary intervention (PCI) is a critical treatment for STEMI.
  • Patient admission pathways may influence treatment timeliness and outcomes.

Purpose of the Study:

  • To evaluate the effect of different admission methods on the timeliness of primary percutaneous coronary intervention (PPCI).
  • To assess the impact of admission ways on in-hospital mortality in STEMI patients undergoing PPCI.

Main Methods:

  • Retrospective analysis of 1,044 STEMI patients undergoing PPCI in Chengdu (2017-2019).
  • Patients categorized into ambulance, self-transport, and transferred groups.
  • Comparison of timeliness metrics (symptom onset to hospital arrival, door-to-balloon time, symptom onset to balloon time) and in-hospital mortality.
  • Multivariate logistic regression to identify determinants of in-hospital death.

Main Results:

  • Ambulance group had significantly shorter total ischemic time and symptom onset to hospital arrival time compared to self-transport and transferred groups.
  • Door-to-balloon time was shorter for ambulance and transferred groups versus the self-transport group.
  • No significant difference in all-cause in-hospital mortality was observed across the three admission groups.
  • Admission way was not a significant predictor of in-hospital death.

Conclusions:

  • Emergency medical services (ambulance) facilitate more timely interventional therapy for STEMI patients.
  • While admission method impacts treatment speed, it does not significantly alter in-hospital mortality for STEMI patients receiving PPCI.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
572
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
164
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
291
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
144
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
117
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
186